|
|
Neuropathy, Hereditary Sensory, Type II
National Organization for Rare Disorders, Inc.
Synonyms
- Congenital Sensory Neuropathy
- Hereditary Sensory and Autonomic Neuropathy, Type II (HSAN Type II)
- HSAN II
- Hereditary Sensory Radicular Neuropathy, Autosomal Recessive
- Radicular Neuropathy, Sensory, Recessive
- Neuropathy, Progressive Sensory, of Children
- Sensory Radicular Neuropathy, Recessive
- Acroosteolysis, Neurogenic
- Acroosteolysis, Giaccai Type
- Morvan Disease
Disorder Subdivisions
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Charcot-Marie-Tooth Disease
- Hereditary Sensory Neuropathy Type I
- Peripheral Neuropathy
- Syringomyelia
- Roussy-Levy Syndrome
General Discussion
The hereditary sensory neuropathies (HSN) include 4-6 similar but distinct inherited degenerative disorders of the nervous system (neurodegenerative) that frequently progress to loss of feeling, especially in the hands and feet. Some types of HSN are related to or identical with some forms of Charcot-Marie-Tooth disorder, and others are related to or identical with familial dysautonomia (Riley-Day syndrome). The classification of the HSNs is complicated, and the experts do not always agree on it.
Hereditary sensory neuropathy type II (HSN2) is a rare genetic disorder that usually begins in childhood by affecting the nerves that serve the lower arms and hands and the lower legs and feet (the peripheral nerves). Symptoms start with inflamed fingers or toes especially around the nails. Infection is common and worsens as ulcers (open sores) form on the fingers and on the soles of the feet. The loss of sensation in both hands and feet often leads to neglect of the wounds. This can become serious, even leading to amputation in extreme cases, so it is important to care for any such wounds.
The disorder affects many of the body’s systems, is characterized by early onset (infancy or early childhood) and is transmitted genetically as an autosomal recessive trait.
Symptoms
Hereditary sensory neuropathy type II is characterized by inflammation of the fingers or toes especially around the nails, usually accompanied by pus and infection and by open sores (ulcers) of the fingers and on the soles of the feet.
Other symptoms include (a) loss of sensation affecting the skin, and sometimes the muscles, tendons, or joints (kinesthetic sensation); (b) loss of feeling in both the arms and legs causing unsteady movement; (c) painless fractures of the limbs that may occur without the patient's awareness; (d) impaired eyesight due to corneal dysfunction; and periodic excessive sweating (hyperhidrosis) followed by shorter periods of lack of ability to sweat (hypohidrosis). Neurological deficits occur in all of the senses.
Some patients with ulcers of the fingers or toes may develop bone complications such as inflammation (osteomyelitis) or breakdown of bone (osteolysis). Left untreated, this may lead to loss of the affected finger or toe.
Causes
Hereditary sensory neuropathy type II is inherited as an autosomal recessive genetic disorder. The faulty gene has been tracked to a location on the short arm of chromosome 12 (12p13.33).
Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated "p" and a long arm designated "q". Chromosomes are further sub-divided into many bands that are numbered. For example, "chromosome 12p13.33" refers to band 13.33 on the short arm (p) of chromosome 12. The numbered bands specify the location of the thousands of genes that are present on each chromosome.
Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.
Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
All individuals carry 4-5 abnormal genes. Parents who are close relatives (consanguineous) have a higher chance than unrelated parents to both carry the same abnormal gene, which increases the risk to have children with a recessive genetic disorder.
Dominant genetic disorders occur when only a single copy of an abnormal gene is necessary for the appearance of the disease. The abnormal gene can be inherited from either parent, or can be the result of a new mutation (gene change) in the affected individual. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy regardless of the sex of the resulting child.
Affected Populations
Hereditary sensory neuropathy type II is a rare disorder present at birth that affects males and females in equal numbers. Symptoms usually develop during infancy or childhood.
In 1973 only 33 cases of HSN2 from 6 families were reported in the medical literature. By 2004 the number of families had increased to 15, representing nearly 50 cases.
Related Disorders
Symptoms of the following disorders can be similar to those of Hereditary Sensory Neuropathy Type II. Comparisons may be useful for a differential diagnosis:
Charcot-Marie-Tooth Disease is a rare hereditary neurological disorder characterized by muscle atrophy and weakness most prominent in the legs and the small muscles of the hands. A decrease in vibration, pain, and thermal sensation in the hand, foot, and lower part of the leg may occur. Stretch reflexes are usually absent. (For more information on this disorder, choose "Charcot-Marie-Tooth Disease" as your search term in the Rare Disease Database.)
Hereditary Sensory Neuropathy Type I is a rare genetic disorder characterized by a loss of sensation usually affecting the feet and legs more severely than the hands and forearms, and by perforating ulcers (open sores) on the feet. Pain and temperature sensations are affected more than touch- pressure sensation. (For more information on this disorder, choose "Hereditary Sensory Neuropathy Type I" as your search term in the Rare Disease Database.)
The symptoms of Peripheral Neuropathy are produced by disease of a single nerve (mononeuropathy, mononeuritis), several nerves in asymmetric areas of the body (mononeuritis multiplex), or many nerves simultaneously (polyneuropathy, polyneuritis, multiple peripheral neuritis). These symptoms may involve sensory, motor, reflex, or blood vessel (vasomotor) function. (For more information on these disorders, choose "neuropathy" as your search term in the Rare Disease Database.)
Syringomyelia is a rare neurological disorder characterized by a fluid- filled cavity (syrinx) within the spinal cord. Patients with Syringomyelia in the upper (cervical and thoracic) part of the spinal cord may first notice loss of feeling for pain and temperature in their fingers, hands, arms, and upper chest. In the early stages, a sense of touch is still present. A loss of feeling may spread over the shoulders and back. Chronic progressive degeneration of the stress-bearing part of a bone joint (Charcot joint) is another symptom. Reflexes in the upper extremities may be absent. When the lumbar and sacral segments of the spine are affected, spasticity, muscle weakness, and muscular incoordination in the lower extremities as well as paralysis of the bladder usually occur. Morvan disease is a severe form of Syringomyelia accompanied by ulceration of fingers and toes. (For more information on this disorder, choose "Syringomyelia" as your search term in the Rare Disease Database.)
Roussy-Levy Syndrome is a rare genetic motor sensory disorder. Major symptoms may include a foot deformity (claw foot), muscle weakness, atrophy of the leg muscles and tremor in the hands. (For more information on this disorder, choose "Roussy-Levy" as your search term in the Rare Disease Database.)
Standard Therapies
Diagnosis Diagnosis of HSN2 depends on clinical, genetic, physiological and pathological criteria. Electromyogram (EMG) and nerve conduction studies may be abnormal. Biopsy of nerve fibers may be used to confirm the diagnosis.
Treatment Treatment of HSN2 is symptomatic and supportive. Genetic counseling may be of benefit for patients and their families.
Investigational Therapies
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222 TTY: (866) 411-1010 Email: prpl@cc.nih.gov
For information about clinical trials sponsored by private sources, go to: www.centerwatch.com
References
McKusick VA, ed. Online Mendelian Inheritance in Man (OMIM). The Johns Hopkins University. Neuropathy, Hereditary sensory and Autonomic, Type II; HSAN2. Entry Number; 201300: Last Edit Date; 5/21/2004.
TEXTBOOKS Mandler S, Pearl PL. Hereditary Sensory Neuropathy Type II. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:571.
Rowland LP, ed. Merritt’s Neurology. 10th ed. Lippincott Williams & Wilkins. Philadelphia, PA. 2000:611.
Menkes JH, Pine Jr JW, et al., eds. Textbook of Child Neurology. 5th ed. Williams & Wilkins. Baltimore, MD; 1995:182.
JOURNAL ARTICLES Auer-Grumbach M. Hereditary sensory neuropathies. Drugs Today (Barc). 2004;40:385-94.
Lafreniere RG, MacDonald ML, Dube MP, et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the study of Canadian Genetic Isolates. Am J Hum Genet. 2004;74:1064-73.
Hilz MJ. Assessment and evaluation of hereditary sensory and autonomic neuropathies with autonomic and neurophysiological examinations. Clin Auton Res. 2002;12 Suppl 1:I33-43
Alibhoy AT, Senanayake B, Fernando MA, et al. A case of hereditary sensory and autonomic neuropathy (HSAN) Type II. Ceylon Med J. 2000;45:32-33.
Shimoya K, Ishimoto S, Ohnishi A, et al. [A case of hereditary sensory autonomic neuropathy type II with late onset] Rinsho Shinkeigaku. 1999;39:551-54.
FROM THE INTERNET Toth C. Autonomic Neuropathy. emedicine. Last Updated: August 17, 2004. 27pp. www.emedicine.com/neuro/topic720.htm
Washington University in St. Louis. Neuromuscular Center. Hereditary Sensory & Autonomic Neuropathies (HSAN) nd. 6pp. www.neuro.wustl.edu/neuromuscular/time/hsn.htm
Hereditary Sensory and Autonomic Neuropathies. Penn State College of Medicine. Faculty Research Expertise Database (FRED). nd. 2pp. http://fred.hmc.psu.edu/ds/retrieve/meshdescriptor/D009477
Toscano E. Hereditary sensory and autonomic neuropathy type IV. Orphanet. Creation date: December 2003. 5pp. http://www.orpha.net/data/patho/GB/uk-HSANIV.pdf
Wilson J. Congenital Insensitivity/Indifference to Pain. contact-a-family. Last updated September 2003. 4pp. www.cafamily.org.uk/userlogin.php
Resources
March of Dimes Birth Defects Foundation
1275 Mamaroneck Avenue White Plains, NY 10605 Tel: (914)428-7100 Fax: (914)997-4763 Tel: (888)663-4637 Email: Askus@marchofdimes.com Internet: http://www.marchofdimes.com
National Institute of Neurological Disorders and Stroke (NINDS)
31 Center Drive 8A07 Bethesda, MD 20892-2540 Tel: (301)496-5751 Fax: (301)402-2186 Tel: (800)352-9424 Email: braininfo@ninds.nih.gov Internet: http://www.ninds.nih.gov/
Jack Miller Center for Peripheral Neuropathy
University of Chicago 5841 S. Maryland Ave, MC 2030 Chicago, IL 60637 Tel: (773)702-5800 Fax: (773)702-5577 Email: information-millercenter@neurology.bsd.uchicago.edu Internet: http://millercenter.uchicago.edu
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for
informational purposes only. NORD recommends that affected individuals seek the advice or counsel of
their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms
listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the
topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease
Database completely current and accurate. Please check with the agencies listed in the Resources section
for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization
for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site
www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 8/17/2007
Copyright 1991, 2004, 2007
National Organization for Rare Disorders, Inc.
|
|
|
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|